Views Navigation

Event Views Navigation

Today

The value of early intervention and continuity of care for mental disorders | ECNP Congress

Vienna

Mood Disorders are a common, chronic, severe, complex and costly group of predominantly recurrent psychiatric illness that can be devastating for the affected individual and their families and impose a high health care related burden. Major depressive disorder and bipolar disorder are the main diagnostic categories in mood disorders. There is a significant clinical need [...]

International Congress for Ataxia Research (ICAR)

Dallas TX

The International Congress for Ataxia Research (ICAR), to be held on 1-4 November 2022, will take place in Dallas, Texas (USA). This Congress will combine the best of our organizations’ popular research meetings, including NAF’s Ataxia Investigators Meeting (AIM) and the International Ataxia Research Conference (IARC), co-led by FARA, Ataxia UK, GoFAR, and other partner [...]

EU Health Summit: Towards an EU Health Union

Brussels

The EU Health Coalition is delighted to invite you to its 3rd EU Health Summit to map the future of the European Health Union. The event will build on the stark lessons learned from COVID-19 and discuss how to go beyond the status-quo in health, seizing opportunities to make positive changes. It will ask what [...]

Local action, regional transformation: WHO Pan-European Mental Health Coalition Meeting

WHO/Europe held the second meeting of its Pan-European Mental Health Coalition on 23–24 November 2022 in Ankara, Turkey, jointly hosted with the fourth Annual Conference on Social Inclusion of Persons with Mental Disabilities. Held in hybrid format, the conference aimed to leverage regional momentum and continue advocating for the necessary actions to improve mental [...]

Psychedelic-assisted therapies in the treatment of brain disorders

European Parliament Rue Wiertz 60, Brussels

The Psychedelic Access and Research European Alliance and European Brain Council were pleased to hold the event, "Psychedelic-assisted therapies in the treatment of brain disorders", hosted by MEPs Jarosław Duda (EPP, PL) and Alex Agius Saliba (S&D, MT) in the European Parliament on 6 December 2022 at 14:00 –16:00 CET. Understanding our brain is an [...]

Rare Neurological Diseases in the EU: The Importance of Early Diagnosis and Real World Evidence to Drive Better Patient Outcomes

European Parliament Rue Wiertz 60, Brussels

On 7 December 2022 at 16:00-17:30, the European Alliance for Patient Access (EAfPA), with support of the European Brain Council (EBC) and European Federation of Neurological Associations (EFNA), hosted an event in the European Parliament on Rare Neurological Diseases in the EU, exploring the importance of early diagnosis and real-world evidence (RWE) to drive better [...]

‘The Future of Brain Health: Clinically Informed & Patient-Centred Brain Research’

European Parliament Rue Wiertz 60, Brussels

EBC Member, the European Academy of Neurology, hosted an event on ‘The Future of Brain Health: Clinically Informed & Patient-Centred Brain Research’ on 8 December in the European Parliament. Held under the auspices of the Czech Presidency of the Council of the European Union and hosted by MEP Ondřej Knotek, the event highlighted [...]

Launch event of the RETHINKING Alzheimer’s disease White Paper

The launch event of the RETHINKING Alzheimer’s disease White Paper, calling for change in Alzheimer’s care, will take place virtually on 24 January 2023 at 12:30 – 14:00. The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), will present its White Paper “RETHINKING Alzheimer’s disease: Detection and diagnosis“. This paper is [...]